169 related articles for article (PubMed ID: 30670057)
1. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Nash RA; Dansey R; Storek J; Georges GE; Bowen JD; Holmberg LA; Kraft GH; Mayes MD; McDonagh KT; Chen CS; Dipersio J; Lemaistre CF; Pavletic S; Sullivan KM; Sunderhaus J; Furst DE; McSweeney PA
Biol Blood Marrow Transplant; 2003 Sep; 9(9):583-91. PubMed ID: 14506660
[TBL] [Abstract][Full Text] [Related]
3. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
McSweeney PA; Nash RA; Sullivan KM; Storek J; Crofford LJ; Dansey R; Mayes MD; McDonagh KT; Nelson JL; Gooley TA; Holmberg LA; Chen CS; Wener MH; Ryan K; Sunderhaus J; Russell K; Rambharose J; Storb R; Furst DE
Blood; 2002 Sep; 100(5):1602-10. PubMed ID: 12176878
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
5. Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.
Maurer B; Hensel M; Max R; Fiehn C; Ho AD; Lorenz HM
Ann Rheum Dis; 2006 Jan; 65(1):127-9. PubMed ID: 15919675
[TBL] [Abstract][Full Text] [Related]
6. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
Nash RA; Bowen JD; McSweeney PA; Pavletic SZ; Maravilla KR; Park MS; Storek J; Sullivan KM; Al-Omaishi J; Corboy JR; DiPersio J; Georges GE; Gooley TA; Holmberg LA; LeMaistre CF; Ryan K; Openshaw H; Sunderhaus J; Storb R; Zunt J; Kraft GH
Blood; 2003 Oct; 102(7):2364-72. PubMed ID: 12763935
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.
Keret S; Henig I; Zuckerman T; Kaly L; Shouval A; Awisat A; Rosner I; Rozenbaum M; Boulman N; Dortort Lazar A; Molad Y; Sabbah F; Naffaa ME; Hardak E; Slobodin G; Rimar D
Rheumatology (Oxford); 2024 May; 63(6):1534-1538. PubMed ID: 37672021
[TBL] [Abstract][Full Text] [Related]
8. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.
Zekri AR; Salama H; Medhat E; Musa S; Abdel-Haleem H; Ahmed OS; Khedr HA; Lotfy MM; Zachariah KS; Bahnassy AA
Stem Cell Res Ther; 2015 Jun; 6(1):118. PubMed ID: 26062731
[TBL] [Abstract][Full Text] [Related]
9. Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.
Dulko AJ; Butrimiene I; Cypiene A; Peceliunas V; Petroska D; Stankeviciene E; Rugiene R
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541223
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease.
Strunz PP; Labinsky H; Nagler LK; Portegys J; Froehlich M; Gernert M; Schmalzing M
Front Immunol; 2023; 14():1294496. PubMed ID: 38045701
[TBL] [Abstract][Full Text] [Related]
11. Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study.
Soloveva M; Solovev M; Mironova D; Mendeleeva L
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):64-74. PubMed ID: 38680711
[No Abstract] [Full Text] [Related]
12. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.
Pecher AC; Klein R; Koetter I; Wagner M; Vogel W; Wirths S; Lengerke C; Henes JC
Arthritis Res Ther; 2024 Mar; 26(1):75. PubMed ID: 38509633
[TBL] [Abstract][Full Text] [Related]
13. The road to purified hematopoietic stem cell transplants is paved with antibodies.
Logan AC; Weissman IL; Shizuru JA
Curr Opin Immunol; 2012 Oct; 24(5):640-8. PubMed ID: 22939368
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis.
Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J
J Scleroderma Relat Disord; 2023 Jun; 8(2):87-100. PubMed ID: 37287946
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of systemic sclerosis.
Manno R; Boin F
Immunotherapy; 2010 Nov; 2(6):863-78. PubMed ID: 21091117
[TBL] [Abstract][Full Text] [Related]
16. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
Brodsky RA; Jones RJ
Autoimmunity; 2008 Dec; 41(8):596-600. PubMed ID: 18958751
[TBL] [Abstract][Full Text] [Related]
17. Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long-Term Normalization of Systemic Sclerosis Molecular Signatures.
Wareing N; Wang X; Keyes-Elstein L; Goldmuntz EA; Lyons MA; McSweeney P; Furst DE; Nash RA; Crofford LJ; Welch B; Pinckney A; Mayes MD; Sullivan KM; Assassi S
Arthritis Rheumatol; 2024 Mar; ():. PubMed ID: 38497141
[TBL] [Abstract][Full Text] [Related]
18. Advances in pathogenesis and treatment of systemic sclerosis.
Denton CP
Clin Med (Lond); 2016 Feb; 16(1):55-60. PubMed ID: 26833515
[TBL] [Abstract][Full Text] [Related]
19. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.
Snowden JA; Badoglio M; Labopin M; Giebel S; McGrath E; Marjanovic Z; Burman J; Moore J; Rovira M; Wulffraat NM; Kazmi M; Greco R; Snarski E; Kozak T; Kirgizov K; Alexander T; Bader P; Saccardi R; Farge D; ; ; ;
Blood Adv; 2017 Dec; 1(27):2742-2755. PubMed ID: 29296926
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients.
Giordano A; Rovira M; Veny M; Barastegui R; Marín P; Martínez C; Fernández-Avilés F; Suárez-Lledó M; Domènech A; Serrahima A; Lozano M; Cid J; Ordás I; Fernández-Clotet A; Caballol B; Gallego M; Vara A; Masamunt MC; Giner À; Teubel I; Esteller M; Corraliza AM; Panés J; Salas A; Ricart E
J Crohns Colitis; 2024 May; ():. PubMed ID: 38757210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
